Global private equity and venture capital news and research

Drug discovery company Novira Therapeutics adds $23m from Canaan Partners, 5AM Ventures

24 Aug 2012

Antiviral drug discovery company Novira Therapeutics has secured $23m in Series A financing co-led by 5AM Ventures and Canaan Partners and joined by WuXi PharmaTech and existing investors BioAdvance, Mid-Atlantic Angel Group, Robin Hood Ventures and Delaware Crossing Investment Group.

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016